Table 1.
Characteristics of the study population.
| Variable | Overall (n= 14,871) |
|---|---|
| Age, years | 50.02 (17.57) |
| Male, % | 7328 (49.3) |
| Education level, % | |
| Below high school | 3259 (21.9) |
| High school | 3330 (22.4) |
| Above high school | 8282 (55.7) |
| Race/ethnicity, % | |
| Mexican American | 1953 (13.1) |
| Other Hispanic | 1541 (10.4) |
| Non-Hispanic White | 5527 (37.2) |
| Non-Hispanic Black | 3342 (22.5) |
| Other race | 2508 (16.9) |
| Poverty, % | 3273 (22.0) |
| Smoker, % | 3482 (23.4) |
| Alcohol user, % | 10641 (71.6) |
| Sedentary time, h | |
| <3 h | 2119 (14.2) |
| 3-6 h | 6868 (46.2) |
| >6 h | 5884 (39.6) |
| Energy intake, kcal/day | 1959.00 [1470.00, 2569.00] |
| Body mass index, kg/m2 | 3.09 (0.85) |
| HDL-C, mg/dL | 1.37 (0.41) |
| Total cholesterol, mg/dL | 190.29 (41.06) |
| Urinary creatinine, mg/dL | 109.00 [61.00, 166.00] |
| Urinary albumin, µg/mL | 8.50 [4.30, 18.50] |
| eGFR, ml/min/1.73 m2 | 93.62 (23.95) |
| Hypertension, % | 5529 (37.2) |
| Diabetes, % | 2107 (14.2) |
| Anti-gout medications, % | 245 (1.6) |
| Diuretics, % | 1828 (12.3) |
| Beta-blockers, % | 1759 (11.8) |
| Uric acid, mg/dL | 5.30 [4.40, 6.40] |
| Hyperuricemia, % | 2766 (18.6) |
| Gout, % | 736 (4.9) |
Data are presented as median (IQR) or n (%); IQR, interquartile range; HDL-C, high-density lipoprotein cholesterol; eGFR, estimated glomerular filtration rate.